Atlas Discovery (YC S26) — AI-native pharma company
Atlas Discovery appears in Y Combinator's company directory in the Summer 2026 batch, listed 2026-06-23. AI-native pharma company.
Atlas Discovery is a Y Combinator company in the Summer 2026 batch. Its directory entry describes it as: AI-native pharma company. The founders listed are Shaamil Karim (Founder/CEO), Sanjukta Bhattacharya (Founder), Christian Gensbigler (Founder) (Y Combinator directory entry, June 23, 2026).
Sell to companies like Atlas Discovery? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
Read from the page's own HTML and response headers on 10 September 2026, at https://atlasdiscovery.bio/. Each badge matched a string the site serves about itself — hover one to see which. Nothing here is a traffic, ranking or revenue figure: those cannot be read off a page and are not claimed.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
Foundation models of patient drug response — trained on pre-clinical and clinical data to design trials that succeed, rescue written-off drugs, and bring once-impossible medicines within reach.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Shaamil Karim
Founder/CEO
Excited about AI for predictive biology
Sanjukta Bhattacharya
Founder
excited about making biology a tractable problem
Christian Gensbigler
Founder
Previously MTS at Origin Bio (YC w26), theoretical biology at Johns Hopkins School of Medicine, math at Dartmouth
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 60 companies held here in Healthcare › Drug Discovery and Delivery.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Atlas Discovery?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Atlas Discovery: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Atlas Discovery covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Atlas Discovery: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
